Apheresis Market Research Report -Global Forecast To 2030

Apheresis Market Research Report, By Products (Devices and Disposables), By Procedures (Plateletpheresis, Leukapheresis, Erythrocytapheresis, Plasmapheresis), By Methods (Centrifugation And Filtration), By Application (Oncological Diseases, Renal Diseases, Cardiovascular Diseases, Haematological Diseases, Neurological Diseases, Immunological Diseases) And By End Users (Blood Banks, Hospitals) – Global Forecast to 2030

ID: MRFR/MED/0979-HCR | August 2022 | Region: Global | 80 Pages         

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL APHERESIS MARKET, BY PRODUCT

5.1 DEVICES

5.1.1 PLASMA SEPARATORS

5.1.2 PLATELETS SEPARATORS

5.1.3 OTHER

5.2 DISPOSABLES

6. GLOBAL APHERESIS MARKET, BY PROCEDURES

6.1 PLATELETPHERESIS

6.2 LEUKAPHERESIS

6.3 ERYTHROCYTAPHERESIS

6.4 PLASMAPHERESIS

6.5 OTHER

7. GLOBAL APHERESIS MARKET, BY METHODS

7.1 CENTRIFUGATION

7.1.1 CONTINUOUS FLOW CENTRIFUGATION

7.1.2 INTERMITTENT FLOW CENTRIFUGATION

7.1.3 OTHER

7.2 FILTRATION

8. GLOBAL APHERESIS MARKET, BY APPLICATION

8.1 ONCOLOGICAL DISEASES

8.2 RENAL DISEASES

8.3 CARDIOVASCULAR DISEASES

8.4 HAEMATOLOGICAL DISEASES

8.5 IMMUNOLOGICAL DISEASES

8.6 NEUROLOGICAL DISEASES

8.7 OTHER

9. GLOBAL APHERESIS MARKET, BY END USERS

9.1 BLOOD BANKS

9.2 HOSPITALS

9.3 OTHER

10. GLOBAL APHERESIS MARKET, BY REGION

10.1 INTRODUCTION

10.2 AMERICA

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.2.2 SOUTH AMERICA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 ITALY

10.3.1.3 SPAIN

10.3.1.5 UK

10.3.1.6 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN

10.4.2 CHINA

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 REPUBLIC OF KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 UNITED ARAB EMIRATES

10.5.2 SAUDI ARABIA

10.5.3 OMAN

10.5.4 KUWAIT

10.5.5 QATAR

10.5.6 REST OF MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

11.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

11.1.1 STRATEGIC PARTNERSHIP

11.1.2 MERGER & ACQUISITION

12 COMPANY PROFILE

12.1 HAEMONETICS CORPORATION

12.1.1 OVERVIEW

12.1.2 PRODUCT OVERVIEW

12.1.3 FINANCIALS

12.1.4 KEY DEVELOPMENTS

12.2 FRESENIUS MEDICAL CARE

12.2.1 OVERVIEW

12.2.2 PRODUCT OVERVIEW

12.2.3 FINANCIALS

12.2.4 KEY DEVELOPMENTS

12.3 TERUMO BCT, INC

12.3.1 OVERVIEW

12.3.2 PRODUCT OVERVIEW

12.3.3 FINANCIALS

12.3.4 STRATEGY

12.3.5 KEY DEVELOPMENT

12.4 ASAHI KASEI MEDICAL CO. LTD

12.4.1 OVERVIEW

12.4.2 PRODUCT OVERVIEW

12.4.3 FINANCIALS

12.4.4 KEY DEVELOPMENTS

12.5 HEMACARE CORPORATION

12.5.1 OVERVIEW

12.5.2 PRODUCT OVERVIEW

12.5.3 FINANCIALS

12.5.4 KEY DEVELOPMENTS

12.6 B. BRAUN MELSUNGEN AG

12.6.1 OVERVIEW

12.6.2 PRODUCT OVERVIEW

12.6.3 FINANCIALS

12.6.4 KEY DEVELOPMENTS

12.7 CERUS CORPORATION

12.7.1 OVERVIEW

12.7.2 PRODUCT OVERVIEW

12.7.3 FINANCIALS

12.7.4 KEY DEVELOPMENTS

12.8 OTHER

13 CONCLUSION

14.1 KEY FINDINGS

14.1.1 FROM CEO’S VIEWPOINT

14.1.2 UNMET NEEDS OF THE MARKET

14.2 KEY COMPANIES TO WATCH

14.3 PREDICTION OF APHERESIS INDUSTRY

15 APPENDIX

Apheresis Market

The Apheresis Market is expected to reach USD 1.9 billion at a 8.9% CAGR during the ongoing forecast period of 2022-2030.

Segmentation

By Products Devices Disposables
By Procedures Plateletpheresis Leukapheresis Erythrocytapheresis Plasmapheresis
By Methods Centrifugation Filtration
By Application Oncological Diseases Renal Diseases Cardiovascular Diseases Haematological Diseases Neurological Diseases Immunological Diseases
By End Users Blood Banks Hospitals

Key Players

  • Asahi Kasei Medical Co. Ltd. (Japan)
  • Fresenius Medical Care (Germany)
  • Terumo BCT Inc. (US)
  • Haemonetics Corporation (US)
  • Kawasumi Laboratories Inc. (Japan)
  • HemaCare Corporation (US)
  • Kaneka Corporation (Japan)
  • and Nikkiso Co.Ltd. (Japan)

Drivers

  • Development in the new apheresis techniques and increasing prevalence of different chronic diseases
  • blood related diseases
Speak to Analyst Request a Free Sample

Apheresis Market Overview


Apheresis market size is expected to grow at a CAGR of 10.2% during the forecast period (2020-2030). Apheresis is a medical procedure that involves the purifying of blood or the separation of distinct blood components. It entails taking blood from a donor or patients and collecting it in a piece of equipment that separates the desired component from the blood while returning the rest to the donor or patients. Two processes were used to separate the components: centrifugation and filtration.


Furthermore, according to the Centers for Disease Control and Prevention (CDC) study, chronic kidney disease affects about 37 million (15%) people in the United States. The Apheresis Market Growth is driven by apheresis, which plays a critical role in the purifying of blood in patients with kidney problems. Along with these considerations, the market Size is being driven forward by increased product innovations and approvals. For example, Fresenius Kabi AG and Fresenius Kabi USA got FDA approval for the ALYX Component Collection System, which is designed to collect and separate whole blood into its constituents in blood collection facilities. As a result of the aforementioned cases shows that the Apheresis Market Trends is predicted to increase steadily over the coming years.


COVID Analysis


Due to the widespread use of plasma therapy in the treatment of COVID-19 infected patients, the Apheresis Market Growth is predicted to benefit during the COVID-19 pandemic. In addition, the US FDA authorized emergency use authorization (EUA) of convalescent plasma (CCP) therapy in hospitalized COVID-19 patients. Terumo BCT Inc. and Marker Therapeutics AG also gained FDA clearance for the Emergency Use Authorization (EUA) of Terumo BCT's Spectra Optia Apheresis System in combination with Marker Therapeutics' D2000 Adsorption Cartridge to treat COVID-19 disease in patients aged 18 and up. As a result of the widespread use of apheresis units in the treatment of COVID-19 patients and growing FDA product approvals, the Apheresis Market Outlook is on the rise.


Apheresis Market Dynamics


Drivers


The Apheresis Market Size is fueled by advancements in innovative apheresis procedures, the rising prevalence of various chronic diseases, blood-related ailments, and biopharmaceutical companies' increasing demand for source plasma, among other factors. Increased demand for various blood components, the increasing complexity of surgical operations, and an increase in the number of accidents throughout the world have all contributed to the market's expansion. Acute disseminated encephalomyelitis, autoimmune hemolytic anemia, and cardiac neonatal lupus are among the novel apheresis indications that have recently been approved. The need for platelets is increasing, according to the National Health Service (NHS) Blood and Transplant which will lead to increased Apheresis Market Share during the forecast period.


Restraints


While a shortage of qualified professionals and the ease with which blood and blood products can be infected, the risk of infection also contributes to the market's slow growth and decreased Apheresis Market Value. However, factors such as the high cost of apheresis devices and therapeutic apheresis procedures, as well as the rental model's installation of apheresis devices, fewer blood donations using apheresis due to lack of awareness, and stringent donor recruitment criteria are expected to limit market growth.


Apheresis is a medical procedure in which a person's blood, whether a donor or a patient, is put through a device that separates a specific ingredient from the rest of the blood and returns it to circulation. Using centrifugation or membrane filtration technology, blood is purified and blood components are separated. This technique is carried out as part of a blood donation or to treat a condition. The apheresis market is divided into two categories based on technology as centrifugation and membrane separation. So, technology plays a vital role in the market.


Study Objectives


The report provides a detailed analysis of the apheresis market, including regional growth and competitive analysis based on the market's leading participants and also a detailed review of the market, as well as the many drivers and restraints influencing the market growth.


An in-depth examination of the market's possible segments and sub-segments is provided. The report also includes regional analysis of the market, which includes the Americas, Europe, Asia Pacific, the Middle East, and Africa. It gives insight into the major countries/places where these major businesses are thriving, as well as identifying unexplored regions that could be future markets.


The report keeps track of and assesses competitive trends in the apheresis industry, including joint ventures, strategic alliances, mergers and acquisitions, new product innovations, and research & development.


Apheresis Market Segment Overview


The Global apheresis market is segmented into products, procedures, methods, applications and end user.


Based on the product, the market is segmented as follows:



  • Devices

  • Plasma Separators

  • Platelets Separators

  • Others

  • Disposables


Based on the procedures, the market is segmented as follows:



  • Plateletpheresis

  • Leukapheresis

  • Erythrocytapheresis

  • Plasmapheresis

  • Others


Based on the methods, the market is segmented as follows:



  • Centrifugation

  • Continuous Flow Centrifugation

  • Intermittent Flow Centrifugation

  • Others

  • Filtration

  • Membrane Separation

  • Selective Adsorption


Based on the application, the market is segmented as follows:



  • Oncological Diseases

  • Renal Diseases

  • Cardiovascular Diseases

  • Hematological Diseases

  • Immunological Diseases

  • Neurological Diseases

  • Others


Based on the end-user, the market is segmented as follows:



  • Blood Banks

  • Hospitals

  • Others


Apheresis Market Regional Classification


The Americas have the biggest regional share of the apheresis market. The expansion of this market in the Americas has been fueled by technological advancements, more opportunities for apheresis products, and the existence of a large number of patients suffering from various chronic conditions. The second-largest market is Europe, which is followed by the Asia Pacific. However, Asia Pacific is the market's fastest-growing region. The Asia Pacific apheresis market is growing due to rising demand for various blood components for patients, rapid advancements in healthcare, and rising healthcare expenditure.


Americas



  • North America

    • US

    • Canada



  • Latin America


Europe



  • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK



  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea



  • Rest of Asia-Pacific


The Middle East & Africa



  • Middle East

  • Africa


Apheresis Market Competitive Landscape


The industry under consideration is moderately competitive and dominated by a few significant firms; yet, the market is well-established in many areas and has a nascent track record of success. However, in poor countries, its full potential has yet to be determined. People are becoming more conscious as a result of increased government activities, which are fueling the market's rise. The industry is also predicted to grow as a result of strategic agreements and new product launches by key companies. The major key players of the market are as follows:



  • Asahi Kasei Medical Co. Ltd. (Japan)

  • Terumo BCT, Inc. (US)

  • Fresenius Medical Care (Germany)

  • Haemonetics Corporation (US)

  • Kawasumi Laboratories Inc. (Japan)

  • HemaCare Corporation (US)

  • Kaneka Corporation (Japan)

  • Nikkiso Co., Ltd. (Japan)

  • Cerus Corporation (US)

  • Braun Melsungen AG (Germany)

  • Therakos, Inc. (US)


Recent Developments


Terumo BCT (US) cooperated with UniCAR-Therapy Bio-Medicine Technology Co. (China). The goal of this collaboration was to establish a new Shanghai Center of Excellence for CAR T-cell treatments. Terumo was able to expand its apheresis and leukapheresis operations as a result of this advancement.


Fresenius Kabi invested EUR 30 million in the Dominican Republic to expand a transfusion and apheresis disposables plant.


In Goa, the Drugs Controller General of India (DGCI) approved the use of apheresis equipment to recover blood plasma from critically ill COVID-19 patients.


Report Overview


The apheresis market report includes thorough primary research as well as detailed qualitative and quantitative analysis by numerous industry professionals and key opinion leaders to acquire a better understanding of the market and industry performance. The overall report depicts the current market landscape in detail, including historical and projected market size in terms of value and volume, technical advancements, macroeconomic considerations, and market controlling factors. The analysis of the report includes detailed information and plans for the industry's top major players. It also provides an overview of the various market categories and geographies.



Report Scope:
Report Attribute/Metric Details
  Market Size   2030 : Significant Value
  CAGR   9.50% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Products, Procedures, Methods, Application and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).
  Key Market Opportunities   Increasing demand for the different component of the bloods
  Key Market Drivers   Development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Global Apheresis Market can expand at 9.50% CAGR from 2020 to 2030.

Increasing prevalence of blood diseases and advances in apheresis equipment can drive the Global Apheresis Market.

Lack of skilled professionals and probability of infections with equipment are concerns of the Global Apheresis Market.

Americas can dominate the Global Apheresis Market till 2023.

Kawasumi Laboratories Inc., Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo BCT, Inc., Fresenius Medical Care, Haemonetics Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, HemaCare Corporation, and Therakos, Inc. are major players of the Global Apheresis Market.